Spotlight Stories
-
Rescuing A Company’s Core Purpose
10/2/2023
When Dr. Scott Braunstein moved from his position as chairman of the board and interim CEO to become permanent CEO of Marinus Pharmaceuticals in August 2019, he had already concluded an overbroad focus was holding the company back.
-
To America, A New Biopharma Model
9/1/2023
Ketan Mehta, founder and CEO of Tris Pharma. Mehta came to the U.S. in the late 1970s. Since then, he has built a career in pharma and, more recently, an entirely new company with a triad of businesses — platform technology licensing, generic medicines, and new drug development.
-
Taking A Fresh Approach To Finance At BMS
9/1/2023
A rising star in BMS’s finance department, Tatiana Simonelli, SVP, finance commercialization at BMS discusses her path to senior leadership, and how talent diversity can boost business results.
-
Biotech Veteran Pushes New Science And Regulatory Change
9/1/2023
Ashvattha Therapeutics CEO Jeff Cleland hopes to bring hydroxyl dendrimer therapeutics to market for the first time, while also pushing for policy and regulatory change as an advocate for BIO.
-
Vincerx Pharma: Finding Strength In Symbiosis
8/1/2023
Ahmed Hamdy and Raquel Izumi are putting the lessons, hard knocks, and experiential wisdom they have gained over a decade in biotech to work at Vincerx.
-
Going European — Affimed’s American CBO
8/1/2023
Taking the CBO position at Affimed offered Denise Mueller a way to apply her skills in an international biotech startup environment, where she could help shape the company’s innovative approach to cancer immunotherapy.
-
Novo Nordisk Returns To Growth, With Growing Pains
8/1/2023
Novo Nordisk’s return to growth is largely due to an explosion of demand for its anti-obesity products. However, challenges with supply and insurance coverage persist.
-
I-MAK’s Quest To Trim The Biopharmaceutical Patent Thicket
7/3/2023
I-MAK, a nonprofit focused on reforming the drug patent system, is bringing patients into the patent system to advocate against abuses that keep affordable drugs out of reach.
-
Civica Takes On Insulin Market, Opens Manufacturing Facility
7/3/2023
With a new manufacturing plant opening in Virgina, Civica is poised to move into new product areas, including affordable insulin.
-
Ways To Face New Bio Funding & Banking Risks
7/3/2023
Funding bio startups has never been easy, but no doubt it just got harder. We wanted to find at least one company to talk about how it is handling the damage and aftermath of recent bank closures and other cash crunches, and we actually found two.